We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nu Skin (NUS) Q4 Earnings: Disappointment in the Cards?
Read MoreHide Full Article
Nu-Skin Enterprises, Inc. (NUS - Free Report) is set to report fourth-quarter 2016 results on Feb 13, after the market closes. The question lingering in investors’ minds is, whether the company will be able to deliver a positive earnings surprise in the to-be-reported quarter.
After delivering in-line earnings for the second quarter, the company posted a positive earnings surprise of 30.5% in the third quarter. Further, the company outpaced the Zacks Consensus Estimate by an average of 7.53% in the trailing four quarters.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Let us see how things are shaping up for this announcement.
Factors to Consider
On Dec 8, the beauty and wellness products company updated its 2016 guidance. It expects revenues of approximately $2.225 billion in 2016.
For the fourth quarter, the company expects earnings per share to be near the high end of the guidance of 77 cents to 81 cents, provided during the third-quarter 2016 conference call. Revenues are expected to be near the low end of its previous outlook of $550 million to $570 million due to the strength in the U.S. dollar.
Nu Skin has been performing really well since the past one year. We note that in the said period the stock increased 83.1% compared with the Zacks categorized Cosmetics & Toiletries industry’s decline of 14.8%. We believe that product innovation has been driving company’s revenues since past many quarters.
In the third quarter, Nu Skin preponed the launch of ageLOC Me in Korea from fourth-quarter fiscal 2016 to third-quarter fiscal 2016, which in turn benefited sales. For the fourth quarter, the company plans to focus its promotional activities on driving consumer loyalty. It plans to execute ageLOC Me incentives in South Korea and South Asia. In the Americas it plans to launch ageLOC Me, and ageLOC Youth in Japan and South Korea.
However, despite the positives, the company faces several regulatory issues. China has always been suspicious about direct selling companies like Nu Skin and Herbalife Ltd. (HLF - Free Report) . Both these companies employ representatives to sell products and are always closely watched by rivals and regulators. They face accusations like focusing more on recruiting rather than product sales and running a pyramid business model – employing deceptive marketing practices for business improvement. The company faces other issues like share inventory write-down and currency headwinds.
Earnings Whispers
Our proven model does not conclusively show that Nu Skin is likely to beat earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here as you will see below.
Zacks ESP: Earnings ESP for Nu Skin is 0.00% as both the Most Accurate estimate and the Zacks Consensus Estimate stands at 80 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Nu Skin has a Zacks Rank #4 (Sell). We caution against Sell-rated stocks (#4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Here are some companies in the consumer staples sector, which are worth considering, as our model shows that they have the right combination of elements to post an earnings beat this quarter:
Sanderson Farms, Inc. has an Earnings ESP of +0.78% and carries a Zacks Rank #3.
Zacks’ Best Private Investment Ideas
In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time?
Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Click here for Zacks' private trades >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Nu Skin (NUS) Q4 Earnings: Disappointment in the Cards?
Nu-Skin Enterprises, Inc. (NUS - Free Report) is set to report fourth-quarter 2016 results on Feb 13, after the market closes. The question lingering in investors’ minds is, whether the company will be able to deliver a positive earnings surprise in the to-be-reported quarter.
After delivering in-line earnings for the second quarter, the company posted a positive earnings surprise of 30.5% in the third quarter. Further, the company outpaced the Zacks Consensus Estimate by an average of 7.53% in the trailing four quarters.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise | Nu Skin Enterprises, Inc. Quote
Let us see how things are shaping up for this announcement.
Factors to Consider
On Dec 8, the beauty and wellness products company updated its 2016 guidance. It expects revenues of approximately $2.225 billion in 2016.
For the fourth quarter, the company expects earnings per share to be near the high end of the guidance of 77 cents to 81 cents, provided during the third-quarter 2016 conference call. Revenues are expected to be near the low end of its previous outlook of $550 million to $570 million due to the strength in the U.S. dollar.
Nu Skin has been performing really well since the past one year. We note that in the said period the stock increased 83.1% compared with the Zacks categorized Cosmetics & Toiletries industry’s decline of 14.8%. We believe that product innovation has been driving company’s revenues since past many quarters.
In the third quarter, Nu Skin preponed the launch of ageLOC Me in Korea from fourth-quarter fiscal 2016 to third-quarter fiscal 2016, which in turn benefited sales. For the fourth quarter, the company plans to focus its promotional activities on driving consumer loyalty. It plans to execute ageLOC Me incentives in South Korea and South Asia. In the Americas it plans to launch ageLOC Me, and ageLOC Youth in Japan and South Korea.
However, despite the positives, the company faces several regulatory issues. China has always been suspicious about direct selling companies like Nu Skin and Herbalife Ltd. (HLF - Free Report) . Both these companies employ representatives to sell products and are always closely watched by rivals and regulators. They face accusations like focusing more on recruiting rather than product sales and running a pyramid business model – employing deceptive marketing practices for business improvement. The company faces other issues like share inventory write-down and currency headwinds.
Earnings Whispers
Our proven model does not conclusively show that Nu Skin is likely to beat earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here as you will see below.
Zacks ESP: Earnings ESP for Nu Skin is 0.00% as both the Most Accurate estimate and the Zacks Consensus Estimate stands at 80 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Nu Skin has a Zacks Rank #4 (Sell). We caution against Sell-rated stocks (#4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Here are some companies in the consumer staples sector, which are worth considering, as our model shows that they have the right combination of elements to post an earnings beat this quarter:
Pinnacle Foods, Inc. has an Earnings ESP of +1.27% and holds a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Sanderson Farms, Inc. has an Earnings ESP of +0.78% and carries a Zacks Rank #3.
Zacks’ Best Private Investment Ideas
In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time?
Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Click here for Zacks' private trades >>